Treatment of Severe COVID-19 with Tocilizumab Mitigates Cytokine Storm and Averts Mechanical Ventilation during Acute Respiratory Distress: A Case Report and Literature Review

COVID-19, caused by the novel severe acute respiratory coronavirus 2 (SARS-CoV-2), emerged in Wuhan, China, in 2019 and has resulted in the current pandemic. The disease continues to pose a major therapeutic challenge. Patient mortality is ultimately caused by acute respiratory distress syndrome (AR...

Descripción completa

Detalles Bibliográficos
Autores principales: Farooqi, Faryal, Dhawan, Naveen, Morgan, Richard, Dinh, John, Nedd, Kester, Yatzkan, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559384/
https://www.ncbi.nlm.nih.gov/pubmed/32635353
http://dx.doi.org/10.3390/tropicalmed5030112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559384/
https://www.ncbi.nlm.nih.gov/pubmed/32635353
http://dx.doi.org/10.3390/tropicalmed5030112

Ejemplares similares